Prognostic impact of ARHGAP43(SH3BP1) in acute myeloid leukemia

CONCLUSION: These findings highlight the clinical potential of ARHGAP43 (SH3BP1) as a novel biomarker of AML, with higher levels indicating a poor prognosis.PMID:38582737 | DOI:10.1016/j.jfma.2024.04.002

Source: J Formos Med Assoc - April 6, 2024 Category: General Medicine Authors: Li Yang Qiang Xu Junnan Li Source Type: research